Giovanna Poce

Pubblicazioni

Titolo Pubblicato in Anno
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment PHARMACEUTICS 2022
Malaria transmission blocking compounds: a patent review EXPERT OPINION ON THERAPEUTIC PATENTS 2022
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment PHARMACEUTICS 2022
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes ANTIOXIDANTS 2021
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy SEMINARS IN CANCER BIOLOGY 2020
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis PHARMACEUTICALS 2020
Overcoming drug resistance in TB: An update FUTURE MICROBIOLOGY 2020
Novel therapies for glaucoma: a patent review (2013-2019) EXPERT OPINION ON THERAPEUTIC PATENTS 2019
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2019
Novel pyrazole-containing compounds active against mycobacterium tuberculosis ACS MEDICINAL CHEMISTRY LETTERS 2019
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects ANTIOXIDANTS 2019
Development of MmpL3 inhibitors for tuberculosis treatment Medicinal Chemistry approaches to tuberculosis and trypanosomiasis 2019
In vivo potent BM635 analogue with improved drug-like properties EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2018
Stimuli-responsive tannin–feIII hybrid microcapsules demonstrated by the active release of an anti-tuberculosis agent CHEMSUSCHEM 2018
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents CHEMISTRY OF HETEROCYCLIC COMPOUNDS 2017
MmpL3 is the flippase for mycolic acids in mycobacteria PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2017
Pharmaceutical salt of BM635 with improved bioavailability EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 2017
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2016

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma